Clinical trial
Early Antenatal Support for Iron Deficiency Anemia: A Randomized Controlled Trial of Early Initiation of Intravenous Versus Oral Iron Therapy for Treatment of Iron Deficiency Anemia in Pregnancy
Name
19G.929
Description
This is a randomized, controlled multi-site trial of iron therapy in pregnancy. The purpose of this research is to see if second trimester initiation of intravenous (IV) iron therapy is better than oral iron therapy for treatment of anemia in pregnancy by improving blood count, quality of life and reducing side effects.
Trial arms
Trial start
2021-09-29
Estimated PCD
2025-08-30
Trial end
2025-12-30
Status
Recruiting
Phase
Early phase I
Treatment
Ferumoxytol
510mg infusion x 2 doses 3-8 days apart
Arms:
Intravenous Iron
Ferrous Sulfate
325mg oral twice daily
Arms:
Oral Iron
Size
80
Primary endpoint
Change in Hemoglobin
90 days
Eligibility criteria
Inclusion Criteria:
* Singleton gestation
* Gestational age \<24 weeks
* Baseline Hb ≥9.0 and \<11.0 with evidence of iron deficiency anemia
Iron deficiency anemia diagnosed (at any point in patient history) by:
* Hb\<11.0
* Ferritin\<30 and/or total iron saturation \<20
Exclusion Criteria:
* Sickle cell Disease (NOT sickle cell trait)
* Evidence of acute anemia requiring transfusion or IV iron therapy
* Major congenital or chromosomal anomaly
* Previous use of IV iron in this pregnancy
* Severe cardiac, renal, or liver disease
* Autoimmune disease (ie Systemic Lupus Erythematosus (SLE)
* Allergy or contraindication to either study drug
* History of medication allergy, reaction to IV infusion, or reaction to Feraheme or other IV iron products
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'Randomized controlled trial', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 80, 'type': 'ESTIMATED'}}
Updated at
2024-04-18
1 organization
2 products
4 indications
Organization
Thomas Jefferson UniversityProduct
FerumoxytolIndication
Pregnancy RelatedIndication
AnaemiaIndication
Iron DeficiencyIndication
Anemia of PregnancyProduct
Ferrous Sulfate